tradingkey.logo
tradingkey.logo
Search

Silence Therapeutics PLC

SLN
Add to Watchlist
10.490USD
-1.130-9.72%
Close 07-31 16:00ETQuotes delayed by 15 min
495.49MMarket Cap
LossP/E TTM

SLN Financials

See Silence Therapeutics PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Silence Therapeutics PLC Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
559.00K
-98.71%
EPS(YoY)
-1.88
-91.51%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021H2
FY2021H1
FY2020H2
FY2020H1
FY2019H2
FY2019H1
FY2018H2
Financial Indicators
EPS
47.58%-0.32
---0.25
40.54%-0.44
-37.88%-0.58
-1016.24%-0.60
----
-166.66%-0.75
-16.71%-0.42
84.29%-0.05
----
---0.28
---0.36
---0.34
----
---0.36
----
----
----
----
----
----
----
----
----
Revenue
197.18%422.00K
--34.00K
-89.29%159.00K
-70.31%224.00K
-99.10%142.00K
----
-58.06%1.48M
-93.38%754.36K
13.90%15.73M
-53.35%2.61M
-10.71%3.54M
148.75%11.39M
80.01%13.81M
--5.59M
--3.97M
--4.58M
--7.67M
58.25%8.95M
461.67%8.11M
1741.16%5.66M
--1.44M
----
----
----
Net Profit
47.57%-14.96M
---11.77M
40.33%-20.96M
-39.34%-27.35M
-1099.17%-28.53M
----
-236.43%-35.12M
-50.84%-19.63M
80.80%-2.38M
-10.90%-17.89M
-24.94%-10.44M
13.29%-13.01M
-20.26%-12.39M
---16.13M
---8.36M
---15.01M
---10.31M
6.09%-26.39M
-100.18%-27.81M
-96.18%-28.10M
-30.88%-13.89M
----
----
----
Net Margin
82.36%-3544.31%
---34617.65%
-457.27%-13181.13%
-369.25%-12211.61%
-132765.50%-20091.55%
----
-702.20%-2365.32%
-2177.83%-2602.34%
83.14%-15.12%
----
---294.85%
---114.25%
---89.71%
----
---209.85%
----
----
----
----
----
----
----
----
----
Gross Margin
57.16%97.39%
--64.71%
141.81%59.75%
118.19%62.05%
-24.57%61.97%
----
-435.73%-142.91%
-595.09%-341.14%
36.62%82.16%
----
--42.57%
--68.90%
--60.14%
----
--44.87%
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
-75.16%0.10%
-66.22%0.14%
----
--0.32%
--0.39%
--0.42%
----
--0.40%
----
----
----
----
----
----
----
----
----
Revenue
197.18%422.00K
--34.00K
-89.29%159.00K
-70.31%224.00K
-99.10%142.00K
----
-58.06%1.48M
-93.38%754.36K
13.90%15.73M
-53.35%2.61M
-10.71%3.54M
148.75%11.39M
80.01%13.81M
--5.59M
--3.97M
--4.58M
--7.67M
58.25%8.95M
461.67%8.11M
1741.16%5.66M
--1.44M
----
----
----
Operating profit
44.61%-15.74M
---12.46M
10.44%-26.24M
2.06%-22.64M
-439.00%-28.41M
----
-82.35%-29.30M
-61.23%-23.11M
64.28%-5.27M
-28.50%-16.51M
-0.29%-16.07M
19.06%-14.34M
-10.89%-14.75M
---12.85M
---16.02M
---17.71M
---13.31M
-13.49%-32.09M
-72.78%-30.89M
-72.35%-28.27M
-42.44%-17.88M
----
----
----
Net Profit
47.57%-14.96M
---11.77M
40.33%-20.96M
-39.34%-27.35M
-1099.17%-28.53M
----
-236.43%-35.12M
-50.84%-19.63M
80.80%-2.38M
-10.90%-17.89M
-24.94%-10.44M
13.29%-13.01M
-20.26%-12.39M
---16.13M
---8.36M
---15.01M
---10.31M
6.09%-26.39M
-100.18%-27.81M
-96.18%-28.10M
-30.88%-13.89M
----
----
----
Current assets
-39.42%102.85M
-36.67%118.66M
--133.63M
-33.38%148.55M
-25.99%169.79M
81.64%187.37M
----
113.23%222.98M
122.28%229.40M
--103.15M
-15.61%106.85M
--104.57M
2.18%103.20M
----
--126.62M
----
--101.00M
11.81%116.80M
12.32%126.30M
110.29%104.46M
326.91%112.45M
32.01%49.68M
-47.95%26.34M
----
Total current liabilities
-45.70%10.46M
-19.08%13.61M
--17.38M
-34.89%14.77M
7.65%19.26M
-24.69%16.82M
----
-8.71%22.68M
-18.32%17.89M
--22.34M
-24.07%21.98M
--24.85M
6.07%21.91M
----
--28.94M
----
--20.65M
-41.32%20.52M
78.32%20.41M
173.21%34.97M
215.47%11.45M
161.95%12.80M
-23.74%3.63M
----
Total assets
-37.87%115.12M
-35.13%131.44M
--146.79M
-30.71%165.23M
-24.48%185.30M
69.64%202.63M
----
102.47%238.47M
110.89%245.37M
--119.45M
-13.70%119.46M
--117.78M
2.08%116.35M
----
--138.42M
----
--113.97M
10.71%130.14M
12.23%139.27M
92.41%117.55M
225.69%124.10M
23.16%61.09M
-39.34%38.10M
----
Total liabilities
-9.42%65.72M
0.77%69.14M
--72.73M
-26.15%71.08M
-18.44%72.56M
-29.60%68.61M
----
-5.84%96.24M
-7.22%88.96M
--97.45M
-5.25%95.07M
--102.21M
-11.82%95.89M
----
--100.33M
----
--108.73M
12.79%118.61M
18.59%106.55M
215.13%105.16M
2375.85%89.85M
582.99%33.37M
-23.74%3.63M
----
Total equity
-56.18%49.40M
-53.51%62.30M
--74.06M
-33.80%94.16M
-27.91%112.74M
509.39%134.02M
----
813.50%142.23M
664.41%156.40M
--21.99M
-35.96%24.39M
--15.57M
290.46%20.46M
----
--38.09M
----
--5.24M
-6.87%11.53M
-4.46%32.72M
-55.32%12.39M
-0.65%34.25M
-38.01%27.72M
-40.62%34.47M
----
Net operating income
-26.76%-15.60M
---17.29M
56.36%-10.89M
-311.26%-21.78M
-36.93%-12.31M
----
-355.92%-24.96M
71.94%-5.30M
1.25%-8.99M
---14.25M
---5.47M
---18.88M
52.78%-9.10M
----
----
----
---19.28M
35.60%-9.71M
1607.60%19.34M
-200.04%-15.08M
108.55%1.13M
246.37%15.07M
-9.96%-13.25M
-49.20%-10.30M
Net investment
122.53%10.00M
---53.34M
234.62%51.29M
-1748.10%-1.56M
11.27%-44.38M
----
-249.93%-38.10M
98.52%-84.52K
-124696.96%-50.02M
---1.24K
--25.41M
---5.73M
43.61%-40.08K
----
----
----
---71.08K
-68.47%12.42M
97.60%-625.69K
308.54%39.41M
-403046.76%-26.07M
-7625.71%-18.90M
99.90%-6.47K
-101.03%-244.58K
Net financing
-100.00%0.00
--0.00
-100.00%0.00
-99.91%1.00K
-99.99%14.00K
----
-49.03%7.76M
-73.18%1.07M
580068.67%133.88M
--12.31M
--15.23M
--3.98M
136.61%23.08K
----
----
----
---63.03K
217.34%579.17K
111.01%42.02M
-107.73%-493.56K
7599.54%19.91M
1874.78%6.39M
106.75%258.62K
--323.52K

FAQs

What is the total revenue of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its total revenue reached 559.00K, with a year-on-year change of 43.26M.

What are the current assets of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its current assets were 118.66M, with a year-on-year change of -36.67.

What are the total assets of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its total assets of Silence Therapeutics PLC were 131.44M, with a year-on-year change of -35.13.

What are the total liabilities of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its total liabilities of Silence Therapeutics PLC were 69.14M, with a year-on-year change of 0.77.

What is the total equity of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its total equity of Silence Therapeutics PLC was 62.30M, with a year-on-year change of -53.51.

What is the net operating income of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its net operating income of Silence Therapeutics PLC was -89.75M, with a year-on-year change of -41.75.

What is the net investment of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its net investment of Silence Therapeutics PLC was -47.99M, with a year-on-year change of -118.48.

What is the net financing of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its net financing of Silence Therapeutics PLC was 15.00K, with a year-on-year change of -99.99.

What is the Earnings Per Share (EPS) of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -1.88, with a year-on-year change of -91.51.

What is the net income of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its net income was -88.61M, with a year-on-year change of -95.57.

What is the net margin of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its net profit margin was -15851.88, with a year-on-year change of -15034.31.

What is the gross margin of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its gross margin was 61.54, with a year-on-year change of -15.35.

What is the Return on Equity (ROE) of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its Return on Equity (ROE) was -90.27, with a year-on-year change of -55.42.

What is the Return on Assets (ROA) of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its Return on Assets (ROA) was -53.05, with a year-on-year change of -88.55.

What is the operating profit of Silence Therapeutics PLC?

According to Silence Therapeutics PLC's FY2025 earnings report, its operating profit was -89.75M, with a year-on-year change of -41.75.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.